Chronic Cluster Headache Clinical Trial
Official title:
Cephalic Vascular Recording Upon SPG Stimulation in CH Patients - Amendment to the Pathway CH-1 Trial
Hypothesis:
Stimulation of the SPG at high frequencies (50-200Hz) is believed to cause a physiological
parasympathetic block which decreases VMCA oxyHb concentration and cephalic vessel diameter.
Stimulation of the SPG at low frequencies (1-60 Hz)is believed to cause a physiological
parasympathetic upregulation which increases VMCA, oxyHb concentration and cephalic vessel
diameter.
Efferent ;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02462395 -
Anodal Transcranial Direct Stimulation (tDCS) for the Treatment of Chronic Cluster Headache
|
Phase 2/Phase 3 | |
| Completed |
NCT05064397 -
A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)
|
Phase 3 | |
| Recruiting |
NCT01701245 -
Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of Care
|
Phase 2 | |
| Completed |
NCT01151631 -
Occipital Nerve Stimulation in Medically Intractable Chronic Cluster Headache
|
Phase 3 | |
| Recruiting |
NCT06124534 -
Bilateral Occipital Nerve Field Stimulation for the Treatment of dtCCH
|
N/A | |
| Unknown status |
NCT00399243 -
Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache
|
Phase 4 | |
| Recruiting |
NCT05868044 -
REsponse to Combined SONS and ONS in Chronic Cluster headachE
|
N/A | |
| Completed |
NCT01616511 -
Pathway CH-1 Long-Term Follow-Up
|
N/A | |
| Completed |
NCT02438826 -
A Study of Galcanezumab in Participants With Chronic Cluster Headache
|
Phase 3 | |
| Completed |
NCT02510729 -
SPG Neurostimulation in Cluster Patients
|
N/A | |
| Active, not recruiting |
NCT02168764 -
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
|
N/A | |
| Completed |
NCT02797951 -
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
|
Phase 3 | |
| Not yet recruiting |
NCT05477459 -
LSD to Improve Cluster Headache Impact Trial
|
Phase 2 | |
| Completed |
NCT03244735 -
Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: a Prospective Case Series
|
N/A | |
| Terminated |
NCT02964338 -
A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)
|
Phase 3 | |
| Completed |
NCT01255813 -
Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache
|
N/A | |
| Active, not recruiting |
NCT05023460 -
Treatment of Chronic Cluster Headache With TENS and ONS
|
N/A |